EUVIMEDEUVIMED entdecken
Crossref

Novel frameshift beta spectrin variant results in clinical spherocytosis type 2

Matthew Crimmins, Prerna Kumar, Mary Beth Ross

Blood Cells, Molecules, and Diseases · 2026-11 · 103054

DOI: 10.1016/j.bcmd.2026.103054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2026-11. Verfasst von Matthew Crimmins und 2 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Crimmins, M., Kumar, P., & Ross, M. B. (2026). Novel frameshift beta spectrin variant results in clinical spherocytosis type 2. Blood Cells, Molecules, and Diseases, 103054. https://doi.org/10.1016/j.bcmd.2026.103054

Vancouver

Crimmins M, Kumar P, Ross MB. Novel frameshift beta spectrin variant results in clinical spherocytosis type 2. Blood Cells, Molecules, and Diseases. 2026:103054. doi:10.1016/j.bcmd.2026.103054

BibTeX
@article{Crimmins2026,
  author = {Crimmins, Matthew and Kumar, Prerna and Ross, Mary Beth},
  title = {Novel frameshift beta spectrin variant results in clinical spherocytosis type 2},
  journal = {Blood Cells, Molecules, and Diseases},
  year = {2026},
  pages = {103054},
  doi = {10.1016/j.bcmd.2026.103054}
}
Kostenlos starten →